Nick Glover
2018
In 2018, Nick Glover earned a total compensation of $1.9M as President and Chief Executive Officer at ProNAi Therapeutics, a 74% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $347,288 |
|---|---|
| Option Awards | $992,417 |
| Salary | $578,813 |
| Other | $23,171 |
| Total | $1,941,689 |
Glover received $992.4K in option awards, accounting for 51% of the total pay in 2018.
Glover also received $347.3K in non-equity incentive plan, $578.8K in salary and $23.2K in other compensation.
Rankings
In 2018, Nick Glover's compensation ranked 5,898th out of 14,244 executives tracked by ExecPay. In other words, Glover earned more than 58.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,898 out of 14,244 | 59th |
Division Manufacturing | 2,239 out of 5,759 | 61st |
Major group Chemicals And Allied Products | 834 out of 2,122 | 61st |
Industry group Drugs | 696 out of 1,811 | 62nd |
Industry Pharmaceutical Preparations | 540 out of 1,385 | 61st |
Source: SEC filing on December 18, 2019.
Glover's colleagues
We found two more compensation records of executives who worked with Nick Glover at ProNAi Therapeutics in 2018.